Who is Pivotal?

The history of our clinical research organization

Transforming for long term value

Pivotal was born in 2001 surrounded by an environment of high scientific tenure and drive. Our founder, Dr. Ibrahim Farr, launched Pivotal to share and implement scientific strategies and best project practices that make clinical trials more efficient and maximize our client’s drug development program’s.

We are a company with as many as 200 employees and operating in more than 22 countries we have built focused specialization across all therapeutic areas and founded a strong oncology, innovative therapies and early phases hub that enable us to tackle our customers’ most difficult challenges. After 20 years of hands-on experience, we master clinical research.

Pivotal has heavily invested in becoming a data- driven CRO that prioritizes mobility. We dive deep into clinical trials by leveraging our near real-time advance analytics and visualization platform. We discover data-driven insights to anticipate trial risks and predict their impact. We are a technology-savvy organization. This has made us an efficient, agile and resilient company that is very focused on our customers.

Our approach to clinical research can be summarized in our Innovative Organizational Model: connected with the clinical research and technology ecosystem, data-driven, agile and customer-centric.


Pivotal Foundation

Pivotal was founded by Dr. Farr


Cross-border trials

Launched the Pivotal´s Partnership Model globally


Pharmacovigilance services

Launched global PVG services


EU Footprint

Started operations in Portugal, Italy, France, Germany and UK


West EU & Central EE Consolidation

Rolled out presence and operations in 7 additional EU countries and covered almost 22 EU countries



Created Danah, our eTMF, CTMS and analytics platform


Patient Journey Services

Acquired Akcelis, a patient journey services company


Pivotal has as many as 200 professionals, (>92% are employees).

Pivotal Leadership Team

Leading through uncertainty and complexity

Pivotal Culture

Builders of a better clinical research world, builders of a great place to work
Dr. Ibrahim Farr
Dr. Ibrahim Farr
Chairman &
Chief Executive Officer

At Pivotal, our purpose is building a better clinical research world. The insights and quality services we provide help build trust and confidence in the clinical research industry.

At Pivotal, our purpose is also building a great firm that attracts, develops, excites and retains exception people. Everyone in the company is responsible for creating leaders around us, for leveraging diversity as an asset.

By doing so, we play a critical role in building a better clinical research world for our people, for our clients and for the patients.

We have built a real value driven organization. Our values act as our ‘North Star’ guiding our people in all our work, from our recruiting interview to our team evaluations, to how we interact with our clients.


We generate trust and closeness. Trust is the single most important ingredient we put in all clinical trials. We deliver transparently as agreed.


We make decisions based on data. We prioritize work based on the impact on our client’s performance indicators. We are predictive, proactive and not reactive.


We strive for quality in everything we deliver, we prioritize clinical quality by design and risk management.


We like to share our knowledge with the clinical research community. We know that as a team, the whole is more than the sum of its parts.


We bring people together with the same values. We are inspired by the lives of our patients. We have integrity in all our actions.

Pivotal Locations

We provide local knowledge with European experience